highperformr logo

Orion Corporation's Overview

Total employees3766
HeadquartersEspoo
Founded1917

Orion Corporation is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs). Committed to 'Building well-being,' Orion focuses on innovation and research to provide solutions for various therapeutic areas, including central nervous system disorders, oncology, and respiratory diseases. The company invests significantly in research and development to bring new treatments to patients worldwide.

Where is Orion Corporation's Headquarters?

HQ Function

Serves as the central hub for corporate management, global strategy, research and development (R&D) leadership, and administrative functions.

Notable Features:

Modern R&D laboratories, advanced manufacturing units for certain products, and collaborative workspaces designed to foster innovation and efficiency. The campus is designed with sustainability considerations.

Work Culture:

A science-driven and innovative environment emphasizing collaboration, continuous learning, high ethical standards, and employee well-being, aligning with its mission 'Building well-being'. Emphasis on expertise and patient-centricity.

HQ Significance:

The Espoo headquarters is pivotal for Orion's global operations, housing key decision-making processes, its primary research and development activities, and advanced manufacturing capabilities. It symbolizes the company's commitment to Finnish innovation.

Values Reflected in HQ: The headquarters reflects Orion's core values of mutual trust and respect, innovation, achieving together, customer focus, and responsibility, evident in its functional design, investment in technology, and focus on a sustainable and supportive work environment.

Location:

Orion Corporation supports a wide range of functions globally, including research and development, manufacturing of APIs and finished dosage forms, extensive sales and marketing operations across Europe, and partnerships for distribution in North America, Asia-Pacific, and other regions. Its products are available in over 100 countries.

Street Address:

Orionintie 1A

City:

Espoo

State/Province:

Uusimaa

Country:

Finland

Orion Corporation's Global Presence

London, United Kingdom

Address: Orion Pharma (UK) Ltd, Suite 1, The Sefton Suite, Ground Floor, Rowlandson House, 289-293 Ballards Lane, London, N12 8NP, UK

To serve the UK healthcare market, ensuring availability and appropriate use of Orion's medicines, and engaging with local health authorities and stakeholders.

Sollentuna, Sweden

Address: Orion Pharma AB, Knistavägen 41-43, Box 520, SE-192 05 Sollentuna, Sweden

To cater to the Swedish pharmaceutical market, providing innovative medicines and support to patients and healthcare providers in Sweden.

Hamburg, Germany

Address: Orion Pharma GmbH, Notkestraße 9, 22607 Hamburg, Germany

To strengthen Orion's presence in the German market, providing therapies in key treatment areas and engaging with the German healthcare community.

Buying Intent Signals for Orion Corporation

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Orion Corporation

As of April 2025, Orion Corporation' leadership includes:

Liisa Hurme - President and CEO
Olli Huotari - SVP, Corporate Functions and CFO
Hao Wu - SVP, Global Operations
Outi Vaarala - SVP, R&D
Sartori Lehtoranta - SVP, Proprietary Products
Virve Laitinen - SVP, Specialty Products and Animal Health

Investors of Orion Corporation

Orion Corporation has been backed by several prominent investors over the years, including:

Orion Pension Fund (Orionin Eläkesäätiö)
The Society of Swedish Literature in Finland (Svenska litteratursällskapet i Finland r.f.)
Various Finnish and international institutional investors
Finnish household investors

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits1

In the past 12-18 months, Orion Corporation saw a key appointment to its Executive Management Board with Hao Wu joining as SVP, Global Operations, succeeding Juhani Kankaanpää who retired. Other changes to the board happened slightly earlier.

Departures

Juhani Kankaanpää, Juhani Kankaanpää retired from his position as SVP, Global Operations, and as a member of the Executive Management Board.

New Appointments:

Hao Wu, Hao Wu appointed as new SVP, Global Operations and member of the Executive Management Board.

Technology (Tech Stack) used by Orion Corporation

Discover the tools Orion Corporation uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Orion Corporation Email Formats and Examples

Orion Corporation primarily uses the 'firstname.lastname@orion.fi' email format for its employees. This is a common format for Finnish and European companies.

firstname.lastname@orion.fi

Format

liisa.hurme@orion.fi

Example

90%

Success rate

News and media

Orion Corporation Stock Exchange ReleaseApril 25, 2024

Orion Corporation: Interim Report January-March 2024

Orion Corporation published its interim report for the period January-March 2024, detailing financial performance and outlook. Net sales were EUR 300 million, and operating profit was EUR 62 million. The company reiterated its outlook for 2024....more

Orion Corporation Press ReleaseApril 4, 2024

Orion's Nouryant® (opikapoone) oral formulation development programme for Parkinson’s patients with swallowing difficulties moves to next phase in the US

Orion announced that the US Food and Drug Administration (FDA) has agreed to the proposed regulatory path for Orion’s investigational new drug (IND), a new oral formulation of Nouryant® (opicapone), known as ODM-109. This formulation aims to assist Parkinson's patients who have difficulties swallowing....more

Orion Corporation Press ReleaseMarch 13, 2024

Orion Corporation and Newel Health collaborate to develop digital therapy for Parkinson's Disease

Orion Corporation and Newel Health announced a strategic collaboration to develop digital therapy solutions for patients with Parkinson's disease. The partnership aims to combine Orion's pharmaceutical expertise with Newel Health's digital health technology....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Orion Corporation, are just a search away.